Tulsa, OK 74136
A Phase 3 Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Upadacitinib in Adolescent and Adult Subjects with Moderate to Severe Atopic Dermatitis
• Ages 12 to 17• Onset of atopic dermatitis symptoms (eczema) for 3 years prior• Must have legal guardian or representative willing to attend study visits
May receive compensation for time and travelAll patient care is free of chargePlacebo or 15 mg Upadacitinib, taken orallyPlacebo or 30 mg Upadacitinib, taken orally
May receive compensation for time and travel
All patient care is free of charge
Placebo or 15 mg Upadacitinib, taken orally
Placebo or 30 mg Upadacitinib, taken orally
Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.